Astena Holdings Co., Ltd. Logo

Astena Holdings Co., Ltd.

Develops and sells chemicals, pharma, and ingredients for food, cosmetic, and industrial use.

8095 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
中央区日本橋本町四丁目8番2号
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Astena Holdings Co., Ltd., formerly Iwaki & Co Ltd, is a diversified holding company established on June 1, 2021, following the transition of the IWAKI Group. The company operates through several core business segments: Fine Chemicals, Health & Beauty Care (HBC), Medical, Food, and Industrial Chemicals. Astena Holdings develops, manufactures, and wholesales a broad portfolio of products, including pharmaceuticals, medical devices, cosmetic ingredients, functional food ingredients, and specialty chemicals. A key subsidiary, Meltex, is a leading provider of surface finishing chemicals used in various industries, including semiconductors.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-07-18 08:03
M&A Activity
臨時報告書
Japanese 28.5 KB
2025-07-11 08:07
Report Publication Announcement
確認書
Japanese 8.1 KB
2025-07-11 08:06
Interim Report
半期報告書-第86期(2024/12/01-2025/11/30)
Japanese 245.6 KB
2025-03-06 07:04
Post-Annual General Meeting Information
臨時報告書
Japanese 23.9 KB
2025-02-27 08:04
Regulatory News Service
内部統制報告書-第85期(2023/12/01-2024/11/30)
Japanese 22.1 KB
2025-02-27 08:03
Regulatory News Service
確認書
Japanese 8.2 KB
2025-02-27 08:02
Annual Report
有価証券報告書-第85期(2023/12/01-2024/11/30)
Japanese 1.4 MB
2025-01-30 07:05
Regulatory News Service
臨時報告書
Japanese 18.7 KB
2024-07-12 08:06
Report Publication Announcement
確認書
Japanese 8.1 KB
2024-07-12 08:05
Quarterly Report
四半期報告書-第85期第2四半期(2024/03/01-2024/05/31)
Japanese 249.6 KB
2024-04-12 08:13
Quarterly Report
確認書
Japanese 8.1 KB
2024-04-12 08:10
Quarterly Report
四半期報告書-第85期第1四半期(2023/12/01-2024/02/29)
Japanese 203.6 KB
2024-03-04 08:10
Regulatory News Service
臨時報告書
Japanese 25.0 KB
2024-02-28 08:35
Registration Form
確認書
Japanese 8.1 KB
2024-02-28 08:34
Governance Information
内部統制報告書-第84期(2022/12/01-2023/11/30)
Japanese 22.1 KB

Automate Your Workflow. Get a real-time feed of all Astena Holdings Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Astena Holdings Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
SoftOx Solutions AS Logo
Develops non-toxic, AMR-safe antimicrobials for wound care, disinfection & airway infections.
Norway SOFTX
Solasia Pharma K.K. Logo
In-licenses and commercializes oncology treatments and supportive care products in Asia.
Japan 4597
Sopharma AD Logo
Develops, manufactures, and distributes pharmaceuticals and generics in Bulgaria and regional markets.
Bulgaria SFA
Spago Nanomedical AB Logo
Developing nanomedicines for precise cancer diagnosis and targeted radionuclide therapy.
Sweden SPAGO
Spexis AG Logo
Clinical-stage biopharma developing macrocyclic therapeutics for rare diseases and oncology.
Switzerland SPEX
Sprint Bioscience Logo
Develops & out-licenses preclinical oncology drugs for difficult-to-treat cancers.
Sweden SPRINT
STADA Arzneimittel AG Logo
A leading European manufacturer of generics, consumer healthcare, and specialty pharmaceuticals.
Germany SAZ
Stayble Therapeutics AB Logo
Develops an injectable drug for lumbar disc herniation pain as an alternative to surgery.
Sweden STABL
STCUBE Logo
Develops first-in-class immunotherapies targeting BTN1A1 for treatment-resistant cancers.
South Korea 052020
STELLA PHARMA CORPORATION Logo
Develops boron drugs for Boron Neutron Capture Therapy (BNCT), a targeted cancer radiation treatment.
Japan 4888

Talk to a Data Expert

Have a question? We'll get back to you promptly.